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Abstract
Background: Common measures of surgical quality are 30-day morbidity and mortality, which poorly describe
breast cancer surgical quality with extremely low morbidity and mortality rates. Several national quality programs
have collected additional surgical quality measures; however, program participation is voluntary and results may
not be generalizable to all surgeons. We developed the Breast Cancer Surgical Outcomes (BRCASO) database to
capture meaningful breast cancer surgical quality measures among a non-voluntary sample, and study variation in
these measures across providers, facilities, and health plans. This paper describes our study protocol, data collection
methods, and summarizes the strengths and limitations of these data.
Methods: We included 4524 women ≥18 years diagnosed with breast cancer between 2003-2008. All women with
initial breast cancer surgery performed by a surgeon employed at the University of Vermont or three Cancer Research
Network (CRN) health plans were eligible for inclusion. From the CRN institutions, we collected electronic administrative
data including tumor registry information, Current Procedure Terminology codes for breast cancer surgeries, surgeons,
surgical facilities, and patient demographics. We supplemented electronic data with medical record abstraction to
collect additional pathology and surgery detail. All data were manually abstracted at the University of Vermont.
Results: The CRN institutions pre-filled 30% (22 out of 72) of elements using electronic data. The remaining
elements, including detailed pathology margin status and breast and lymph node surgeries, required chart
abstraction. The mean age was 61 years (range 20-98 years); 70% of women were diagnosed with invasive ductal
carcinoma, 20% with ductal carcinoma in situ, and 10% with invasive lobular carcinoma.
Conclusions: The BRCASO database is one of the largest, multi-site research resources of meaningful breast cancer
surgical quality data in the United States. Assembling data from electronic administrative databases and manual
chart review balanced efficiency with high-quality, unbiased data collection. Using the BRCASO database, we will
evaluate surgical quality measures including mastectomy rates, positive margin rates, and partial mastectomy re-
excision rates among a diverse, non-voluntary population of patients, providers, and facilities.
Introduction
The Institute of Medicine report “Crossing the Quality
Chasm”, emphasized high quality care should be safe,
timely, effective, efficient, equitable, and patient-centered
[1]. The common measures of surgical quality are 30-
day morbidity and mortality, which are not ideal metrics
for breast cancer procedures that have extremely low
morbidity and < 0.5% mortality. These measures only
reflect outcomes of surgery, but do not consider the sur-
gical process or institutional structure - other aspects
that can influence the overall procedure quality [2]. Sev-
eral experts have agreed that the quality of cancer sur-
gery is currently the “black box” of cancer care, subject
to wide variability at provider-, facility-, and regional-
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measures [3].
The University of Vermont Breast Cancer Surgical Out-
comes (VBCSO) database was developed in 2003 to estab-
lish the feasibility of measuring potential breast cancer
surgical quality indicators [4]. The VBCSO database
included 910 women diagnosed with breast cancer
between April 1, 2003- March 30, 2008 who underwent
initial breast cancer surgery at a single institution. Trained
nurses abstracted medical record data on initial mastect-
omy rate, close and positive margin rates, number of sur-
geries, number of lymph nodes obtained during sentinel
node biopsy and/or axillary dissection, use of intraopera-
tive pathology assessment for sentinel nodes, and days
between diagnosis and initial surgery. Subsequently, these
data have demonstrated variation in surgical outcomes
among surgeons who practice at one institution [4].
We extended the VBCSO database to three Cancer
Research Network (CRN) health plans to develop a
large, non-voluntary, multi-institution database to study
breast cancer surgical quality. The CRN is a consortium
of 14 non-profit research centers based in integrated
healthcare delivery organizations within the HMO
Research Network [5]. The purpose of this paper is to
describe the combined Breast Cancer Surgical Outcomes
(BRCASO) research database, structure, data elements,
and study methods in detail, including important lessons
learned in collecting surgical outcomes data. We plan to
use these data to evaluate variation in surgical quality
measures (initial mastectomy rate, initial partial mastect-
omy positive margin rate, and initial partial mastectomy
re-excision rate) by patient-, surgeon-, facility-, and
region-level factors.
Methods
Data from the VBCSO database were combined with data
from three CRN health plans (Group Health Cooperative,
Kaiser Permanente Colorado, and Marshfield Clinic) to
form a single, large, multi-site database called BRCASO,
which resides at the Van Andel Research Institute
(VARI). All study procedures were approved by Institu-
tional Review Boards at the University of Vermont,
VARI, and Kaiser Permanente Colorado (through coop-
erative review for the CRN health plans); we received a
waiver of consent to collect patient and provider-level
data. The waiver was granted based on the fact that this
study was a retrospective review of standard treatment
data and of minimal risk to the patients; all identifiable
information was kept at local sites, and only a deidenti-
fied data set was shared for analysis and reporting.
Study population
A total of 6095 women ≥18 years old were diagnosed
with stage 0-IV breast cancer between January 1, 2003
and December 31, 2008. To be eligible for inclusion in
the database, women had to have their initial breast can-
cer surgery performed by a surgeon employed by the
University of Vermont or one of the CRN health plans
(including CRN health plan-contracted facilities). We
included all women with ductal carcinoma in situ
(DCIS), invasive ductal (IDC) or lobular carcinoma
(ILC); all other breast pathologies were excluded. We
also excluded males, women with initial surgery at an
external facility by a non-CRN health plan-employed
surgeon, women with breast cancer diagnosed on pro-
phylactic mastectomy, and women with breast cancer
diagnosed but never treated surgically.
BRCASO database
The BRCASO database is stored on a SQL server 2008
database at VARI, the primary site for this research.
Because of the multi-site nature of this study, we fol-
lowed strict security procedures to ensure confidentiality
of data transfer to VARI. Figure 1 shows electronic lim-
ited data sets from each CRN institution were collated
at a single site (Kaiser Permanente Colorado), before
transfer to VARI through a Secure File Transfer Proto-
col (SFTP) site using Secure Shell (SSH2) encryption.
The University of Vermont transferred electronic data
directly to VARI using the same SFTP site. Figure 2
shows chart data were abstracted at individual institu-
tions and entered into a secure (HTTPS) online web
application hosted by VARI. VARI stored and collated
all electronic and chart abstracted data behind their fire-
w a l l ,w h e r et h e yw e r eo n l ya c c e s s i b l et op r o g r a m m e r s
and system administrators at VARI.
Electronic administrative data
Each CRN health plan collects electronic administrative
data on inpatient and outpatient procedures, health plan
enrollment, pharmacy dispensings, laboratory tests, and
other elements as part of clinical care. Each health plan
also links to their local Surveillance, Epidemiology and
End Results (SEER) or state cancer registry. All electro-
nic data elements for CRN sites are part of the Virtual
D a t aW a r e h o u s e( V D W )w h e r et h e ya r ef o r m a t t e di na
standard fashion across sites, but the data themselves
are housed at each individual site [5]. For BRCASO, a
programmer at one site wrote programs to identify eligi-
ble breast cancer cases and extract relevant administra-
tive data that could be run against the VDW at each
site. We extracted electronic information from: tumor
registry data on diagnosis date, diagnosis type, laterality,
estrogen and progesterone receptor status, and tumor
grade; inpatient and outpatient Current Procedure Ter-
minology (CPT-4) codes including date and type of pro-
cedures (partial mastectomies, total mastectomies, and
lymph node surgeries) with de-identified surgeon and
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weight, geocoded income and education, ethnicity, race,
and insurance type. These data were used to prefill the
BRCASO database to reduce the amount of information
that needed to be collected manually from the medical
records.
Abstracted medical record data
Each site reviewed their own electronic medical
records for women eligible for the study. All abstrac-
tors had previous experience abstracting cancer
patients’ medical records. We developed a detailed
data manual to standardize abstracted information
(Additional file 1). This comprehensive manual pro-
vided not only data definitions, but also preferences
for which clinical report information was generally
most accurate and an overall context of how the data
element would be used in this study. Chart abstraction
was piloted at each institution using paper forms and
results for 10 cases from each site were discussed via
teleconference before finalizing the manual and data-
base. All electronic pre-filled data were viewable within
the database, and could be edited if discrepancies were
noted between administrative and chart data. Each
patient was automatically marked as complete once
every data field was complete, and the record was then
routed to a SQL database at VARI.
Clinical details abstracted from medical records included
￿ Surgical breast procedures (multiple records per per-
son allowed): indication (known malignancy vs. undiag-
nosed breast lesion), anesthesia type, tumor localization
technique, intra-operative margin assessment, surgeon
specimen orientation technique, breast reconstruction
Figure 1 Shows how electronic data were transferred from each Cancer Research Network site (Marshfield and Group Health) to KPCO
(Kaiser Permanente Colorado) before transfer to VARI (Van Andel Research Institute). Vermont transferred data directly to VARI. Data were
routed through the VARI FTP (File Transfer Protocol) server and underwent initial validation before transfer to the BRCASO database.
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and distance of closest uninvolved margins by invasive
carcinoma and/or DCIS, direction of margins involved
(i.e. positive margin) by invasive carcinoma and/or DCIS
￿ Tumor information: tumor sizes (pathologic and as
estimated by imaging prior to first treatment), size of
invasive and DCIS components, presence of residual
tumor in first and subsequent surgical specimens, syn-
chronous tumors, final pathological diagnosis, lympho-
vascular invasion, perineural invasion, HER2 result,
prophylactic mastectomy pathology
￿ Lymph nodes: type of procedure (sentinel lymph
node [SLN] biopsy, axillary sampling/dissection), intra-
operative SLN evaluation, SLN histology, SLN and axil-
lary positive and total node counts
￿ Other: Neoadjuvant treatment, imaging performed,
known multi-focal and multi-centric status pre-opera-
tively, prior breast cancer history
Quality control
Each chart abstractor was trained by the lead chart
abstractor at the University of Vermont. Regular
abstractor meetings occurred throughout the funding
period to address specific questions. Chart abstractors
could also post questions to a private SharePoint site
that were answered by the lead chart abstractor or prin-
cipal investigator and then disseminated to all abstrac-
tors for review. After completing 1,000 charts, we
reviewed frequencies of BRCASO data elements by insti-
tution to check for inconsistencies, missing data, or
Figure 2 Shows how chart abstraction data were collected from each Cancer Research Network site (KPCO [Kaiser Permanente
Colorado], Marshfield, and Group Health) and Vermont and entered into a secure (HTTPS) online web application hosted by VARI.
Data underwent initial validation before transfer to the BRCASO database.
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provided back to each site, where abstractors confirmed
any inconsistencies and made changes to the BRCASO
database if needed. We continued to review frequencies,
perform variable cross-checks, and clean data as neces-
sary throughout the abstraction period. The database
was designed to keep a detailed log of all entries and
edits to the data by user ID to maintain data integrity.
Results
We have complete data on 4524 of 6095 women (74.2%)
and their surgeries in the BRCASO database, to date.
The mean age was 61 years (range 20-98 years) and 94%
of the study population was white. Approximately 40%
of the study population were insured by Medicare and
4% by Medicaid. Nearly 70% of women were diagnosed
with IDC, 20% with DCIS, and 10% with ILC.
By using electronic administrative data, CRN health
p l a n sp r e - f i l l e d2 2o f7 2( 3 0 %) data fields. The remain-
der of the 50 fields required abstraction from the medi-
cal record. In addition, several electronic data fields
occasionally required editing by the chart abstractor to
update and clarify diagnosis and procedure dates, per-
forming surgeon, surgical facility, and lymph node pro-
cedures. The total time for chart abstraction ranged
from 30-90 minutes per chart depending on the number
of surgeries per woman, and the availability of pathology
and operative reports within the medical record. A list
of potential quality measures that will be evaluated
using these data for variation across women, surgeons,
and facilities are in Table 1. We specifically selected
eight measures that we felt would be meaningful to
patients and were previously evaluated in the VBCSO
database; [4] we included two additional measures (use
of needle biopsy for pre-operative diagnosis, and use of
neoadjuvant chemotherapy for T2/T3 tumors) that
showed broad variation during data collection. In gen-
eral, these were regularly recorded and easily found in
automated data or medical records, which increases the
adaptability of our methods to other institutions.
Discussion
Developing quality measures for breast cancer surgery is
critical given the high frequency of surgical breast pro-
cedures and potential variation that exists across facil-
ities and surgeons. Wasif et al. comment that quality
measures must 1) be acceptable to various stakeholders;
2) include measureable elements; and 3) impact out-
comes [2]. While several national and international
groups have developed quality cancer care measures,
most focus on treatment other than breast surgery and
participation in these programs tends to be voluntary.
BRCASO aims to develop a more comprehensive, vali-
dated set of breast cancer surgical quality measures, and
use these data to conduct research on surgical quality
variation among a generalizable (i.e. non-voluntary)
population.
Current quality measurement programs for cancer
care delivery, while valuable, are limited in their ability
to specifically address surgical quality and provide
detailed data for research. Two of these programs,
QOPI - ASCO’s Quality Oncology Practice Initiative [6]
and the American College of Surgeons’ (ACoS) Com-
mission on Cancer (CoC), [7] are primarily geared
toward measuring and documenting overall quality of
cancer care. Together, the CoC and American Cancer
Society developed the National Cancer Data Base, one
of the largest national registries of new cancer diag-
noses. The data collected for each of these efforts pri-
marily relate to documentation and treatment other
than surgery.
One recent program dedicated primarily to breast care
quality improvement is the American Society of Breast
Surgeons’ Mastery of Breast Surgery Program, another
voluntary initiative that helps surgeons document their
clinical performance; early results showed program
Table 1 Potential surgical quality measures to be evaluated using BRCASO data
SURGICAL OUTCOME MEASURE
PRIMARY TUMOR Mastectomy rate
Positive/close margin rate following initial partial mastectomy
Partial mastectomy re-excision rate
Use of needle biopsy for pre-operative diagnosis
Use of neoadjuvant chemotherapy for T2/T3 tumors
AXILLARY MANAGEMENT Number of sentinel nodes identified
Intra-operative lymph node assessment
Nodes examined following axillary dissection
Completion axillary dissection rate following positive sentinel lymph node
HEALTH CARE DELIVERY Initial breast cancer surgery within 30 days
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demic settings was low [8]. Facilities may also receive
certification from the National Accreditation Program
for Breast Centers (NAPBC) [9]. Accredited breast cen-
ters are required to meet certain surgical standards
including > 50% of early stage breast cancer patients
treated with breast conserving surgery, SNL for all
patients with stage I or II disease, and diagnosis with
palpation- or image-guided biopsy rather than open
biopsy.
Perhaps the most detailed surgical quality measures
come from the National Consortium of Breast Centers,
Inc. and its National Quality Measures for Breast Cen-
ters (NQMBC) program [10]. The NQMBC’sq u a l i t y
measures include 37 measures for breast cancer diagno-
sis and treatment including surgical timeliness, pathol-
ogy timeliness, pathology report completeness (tumor
size, margins, lymph nodes, and specimen sampling ade-
quacy), sentinel node biopsy, breast conservation surgery
rate, and re-excision rate. The program includes over
200 voluntary participants and allows them to compare
their performance with other centers across the US.
Members can collect all measures or a select few
depending on their certification level. The validity of
some of these measures as reasonable quality measures
has not been tested in a broad population of patients.
T h ed a t ac o l l e c t e df r o mt h eB R C A S Os t u d yw i l l
enable us to evaluate a number of quality measures spe-
cific to breast cancer surgery. Our three initial proposed
surgical quality measures are 1) initial mastectomy rate,
2) initial partial mastectomy positive margin rate, and 3)
initial partial mastectomy re-excision rate. At this time,
we are not recommending benchmarks for these mea-
sures, but instead, will evaluate variability in these mea-
sures by patient-, surgeon-, facility-, and regional-level
factors, and by invasive and in situ diagnoses that may
inform future benchmarks. We will be able to control
these outcomes for clinical factors such as estimated
tumor size, known multi-centric disease, breast imaging,
anesthesia, localization technique, neo-adjuvant treat-
ment, and detailed tumor characteristics. We also have
detailed data on timeliness of procedures, extent of
lymph node procedures, positive node counts, and
reconstruction, which may serve as additional surgical
quality measures. Most importantly, we have collected
margin status for each procedure performed, which is
important in assessing surgical quality and cannot be
extracted from tumor registry data.
The BRCASO database has the potential to be one of
the largest, multi-site breast cancer surgical quality
research databases to-date. The research possibilities
may extend even beyond surgical quality measures. One
of the major differences between BRCASO and the
national efforts described above is that BRCASO does
not rely on voluntary reporting. BRCASO includes a
diverse geographic sample of all surgeons who practice
at our varied institutions (health maintenance organiza-
tion, university hospital, contracted community hospi-
tals). In addition, a proportion of the data from the
CRN sites were collected from electronic administrative
data, a process that has the potential to be extended to
other organizations with similarly organized billing data.
However, the BRCASO database is not without limita-
tions. Our electronic administrative data were less suffi-
cient than we had hoped for in pre-filling the database.
Thus our chart abstraction took longer than we antici-
pated, and we fell short of the originally anticipated
6,095 cases. We have no detailed information on sur-
geon training, surgeon specialty, patient breast size,
family history or patient preferences - all of which can
account for variability in surgical procedures and qual-
ity. The focus of BRCASO was to collect data on speci-
fic short-term surgical outc o m e ss u c ha sr e e x c i s i o n s
rates; thus we do not have data on long-term outcomes
of recurrence or mortality, but plan to expand our
efforts to collect these data in the future.
We learned several important lessons that others may
want to consider when collecting surgical quality data.
First, while electronic administrative data were useful in
prefilling some of our data elements, they have serious
limitations. Most importantly, there is no way to get
accurate detailed margin or lymph node data from elec-
tronic administrative data; re-excision data may also be
inaccurate as repeat procedures do not appear to be
well documented in electronic data. Tumor registry data
generally represent final surgical procedure and final
pathology, but do not offer a clear characterization of
multiple procedures that a patient may receive. The
CoC database does collect information on positive/nega-
tive margin status, but does not include detail on mar-
gin distance or direction. Until more detailed, standard
definitions are developed and implemented, we can only
obtain detailed surgical quality data through medical
record abstraction; but these data are time consuming
and expensive to collect. We noted modest variation in
the information provided in pathology, surgical opera-
tive, and other clinical reports between organizations
and facilities. While standardizing these reports across
institutions would be ideal, it was not possible in this
retrospective study. Therefore, having highly trained
medical record abstractors, a detailed coding manual,
and regular channels for abstraction-related queries
were invaluable to reducing data discrepancies in our
studies.
Collecting a large amount of multi-site surgical quality
data is a complex task - but the potential benefits and
knowledge gained may be substantial. While some of
the national efforts mentioned here will provide larger
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care, only one (the NQMBC program) appears to collect
the level of detail needed to evaluate quality of surgical
care. These databases also rely solely on self-reported
information from providers who opt-in to each system,
and may be more likely to involve high volume breast
surgeons. These providers may not be representative of
the national population of surgeons because many sur-
geons performing breast surgery in the United States are
neither high volume breast surgeons nor work within a
certified breast center [8]. Our study collected data on
every surgeon who performs breast procedures at one of
four geographically disparate institutions, with variable
volume in breast surgery. Standardizing clinical data col-
lection and reporting efforts across programs and data-
bases (including ours), with institutional participation
rather than voluntary, and publicly reporting results will
likely be necessary to develop timely benchmarks for
surgical quality. Additional programming work, such as
Natural Language Processing, may help improve data
collection timeliness and efficiency by automatically
interpreting text from electronic medical records, thus
reducing the need for manual abstraction. Creating stan-
dard templates in electronic medical records for pathol-
ogy and surgery reports may be another method that
can improve both quality and consistency of data col-
lected and reported. We hope the work from BRCASO
provides a stepping stone for research on and develop-
ment of standard surgical quality measures that can be
generalized to and implemented by other providers and
institutions.
Additional material
Additional file 1: BRCASO chart abstraction manual. Detailed chart
abstraction methods and protocol used in the BRCASO study.
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